本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

TriSalus Life Sciences Inc.

5.18
+0.04760.93%
成交量:1.35萬
成交額:6.93萬
市值:1.67億
市盈率:-3.95
高:5.28
開:5.13
低:5.00
收:5.13
資料載入中...
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/21

SEC問詢函

Form CORRESP - Correspondence
2023/12/21

SEC問詢函

Form CORRESP - Correspondence
2023/12/15

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/12/15

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/14

SEC問詢函

Form CORRESP - Correspondence
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/10/19

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/18

SEC問詢函

Form CORRESP - Correspondence
2023/10/16

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/02

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/31

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/08/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/23

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/21

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/21

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership